CVS Health Corporation (CVS)
CVS Health Q1 Earnings Call Highlights
CVS Health NYSE: CVS raised its full-year 2026 adjusted earnings outlook after reporting stronger first-quarter results, with management citing improved performance at Aetna, continued execution at Caremark and resilient pharmacy operations.
CVS Health: Rapidly Improving Metrics And Promising Recovery Deserve Reiterated Buy Rating
The +2.48% YoY payment hike for 2027 Medicare Advantage plans and Aetna's higher star rating support CVS Health's recovery prospects toward 2028 target margins. This is significantly aided by the prior premium re-pricing and the ongoing operational efficiencies, as observed in their FQ1 '26 MBR of 84.6% nearing 2019 levels. Readers must not forget their vertically integrated PBM and pharmacy capabilities, allowing them to drive lower medical costs and improved operational efficiencies.
CVS Health Q1 Earnings: We're (Finally) Back In Buy Territory
CVS Health Corporation delivered a strong Q1, with revenues of $100.4bn and adjusted EPS up ~14% to $2.57, surpassing expectations. CVS raised 2026 guidance: revenue to $405bn, adjusted EPS to $7.4, and cash flow from operations to $9.5bn, reflecting renewed operational momentum. Improvement in the medical benefit ratio to 84.6% and robust health insurance segment profitability signal a turnaround in CVS's core business.
CVS Health Corporation (CVS) Q1 2026 Earnings Call Transcript
CVS Health Corporation (CVS) Q1 2026 Earnings Call Transcript
CVS Health tops Q1 estimates, raises full-year guidance
CVS Health Corp (NYSE:CVS) shares rose about 6% on Wednesday morning after the retail pharmacy chain reported first quarter financial results that topped Wall Street expectations on both earnings and revenue. The company posted adjusted earnings per share (EPS) of $2.57, compared with analyst estimates of $2.21.
CVS Health Q1 Earnings & Revenues Top Estimates, Stock Up in Pre-Market
CVS beats Q1 estimates as revenues hit $100.43B, margins expand, and 2026 guidance is raised. Shares jump 4.8% in pre-market.
CVS Health (CVS) Beats Q1 Earnings and Revenue Estimates
CVS Health (CVS) came out with quarterly earnings of $2.57 per share, beating the Zacks Consensus Estimate of $2.21 per share. This compares to earnings of $2.25 per share a year ago.
CVS Health raises 2026 forecast after improving medical cost controls
CVS Health raised its full-year forecast on Wednesday, aided by increased first-quarter earnings in the company's pharmacy management business and strong medical cost controls in its government-sponsored health plans.
CVS blows past estimates, hikes outlook as insurance business outperforms
CVS Health on Wednesday blew past first-quarter earnings and revenue estimates and raised its 2026 guidance, as its once-troubled insurance business showed improvement. All of the health-care giant's business segments, including its insurer Aetna, its retail pharmacy and health services unit, surpassed Wall Street's expectations.
CVS Health (CVS) Stock Slides as Market Rises: Facts to Know Before You Trade
In the closing of the recent trading day, CVS Health (CVS) stood at $82.44, denoting a -1.03% move from the preceding trading day.
Countdown to CVS Health (CVS) Q1 Earnings: Wall Street Forecasts for Key Metrics
Looking beyond Wall Street's top-and-bottom-line estimate forecasts for CVS Health (CVS), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended March 2026.
How CVS Uses Robots to Keep Your Deodorant in Stock
The pharmacy chain's first highly automated warehouse uses robots to handle millions of items a week with a fraction of the usual staff.
